These studies suggest that DUSP1 plays a significant role in NSCLC by regulating MAPK signaling pathways, and DUSP1, in association with several other pathway factors, modulates lung cancer tumor progression, angiogenesis, invasion, metastasis, drug resistance, and apoptosis in NSCLC. This evidence concerns the gene DUSP1 and lung carcinoma.